| Year |
Citation |
Score |
| 2020 |
Baqi Y, Rashed M, Schäkel L, Malik EM, Pelletier J, Sévigny J, Fiene A, Müller CE. Development of Anthraquinone Derivatives as Ectonucleoside Triphosphate Diphosphohydrolase (NTPDase) Inhibitors With Selectivity for NTPDase2 and NTPDase3. Frontiers in Pharmacology. 11: 1282. PMID 32973513 DOI: 10.3389/Fphar.2020.01282 |
0.332 |
|
| 2020 |
Li W, Guillaume J, Baqi Y, Wachsmann I, Gieselmann V, Van Calenbergh S, Müller CE. Synthesis and structure-activity relationships of cerebroside analogues as substrates of cerebroside sulphotransferase and discovery of a competitive inhibitor. Journal of Enzyme Inhibition and Medicinal Chemistry. 35: 1503-1512. PMID 32657203 DOI: 10.1080/14756366.2020.1791841 |
0.311 |
|
| 2020 |
Tian M, Abdelrahman A, Baqi Y, Fuentes E, Azazna D, Spanier C, Densborn S, Hinz S, Schmid R, Müller CE. Discovery and structure-relationships of salicylanilide derivatives as potent, non-acidic P2X1 receptor antagonists. Journal of Medicinal Chemistry. PMID 32345019 DOI: 10.1021/Acs.Jmedchem.0C00435 |
0.457 |
|
| 2020 |
Müller CE, Baqi Y, Namasivayam V. Agonists and Antagonists for Purinergic Receptors. Methods in Molecular Biology (Clifton, N.J.). 2041: 45-64. PMID 31646479 DOI: 10.1007/978-1-4939-9717-6_3 |
0.42 |
|
| 2019 |
Attah IY, Neumann A, Al-Hroub H, Rafehi M, Baqi Y, Namasivayam V, Müller CE. Ligand binding and activation of UTP-activated G protein-coupled P2Y and P2Y receptors elucidated by mutagenesis, pharmacological and computational studies. Biochimica Et Biophysica Acta. General Subjects. 129501. PMID 31812541 DOI: 10.1016/J.Bbagen.2019.129501 |
0.425 |
|
| 2019 |
Mouro FM, Köfalvi A, André LA, Baqi Y, Müller CE, Ribeiro JA, Sebastião AM. Memory deficits induced by chronic cannabinoid exposure are prevented by adenosine AR receptor antagonism. Neuropharmacology. 155: 10-21. PMID 31103616 DOI: 10.1016/J.Neuropharm.2019.05.003 |
0.375 |
|
| 2019 |
Jiang J, Seel C, Temirak A, Namasivayam V, Arridu A, Schabikowski J, Baqi Y, Hinz S, Hockemeyer J, Müller CE. A2B Adenosine Receptor Antagonists with Picomolar Potency. Journal of Medicinal Chemistry. PMID 30835463 DOI: 10.1021/Acs.Jmedchem.9B00071 |
0.427 |
|
| 2019 |
Armida M, Matteucci A, Pèzzola A, Baqi Y, Müller CE, Popoli P, Potenza RL. Modulating P1 Adenosine Receptors in Disease Progression of SOD1 Mutant Mice. Neurochemical Research. PMID 30756215 DOI: 10.1007/S11064-019-02745-0 |
0.39 |
|
| 2018 |
Baqi Y, Müller CE. Antithrombotic P2Y receptor antagonists: recent developments in drug discovery. Drug Discovery Today. PMID 30291899 DOI: 10.1016/J.Drudis.2018.09.021 |
0.443 |
|
| 2018 |
Faivre E, Coelho JE, Zornbach K, Malik E, Baqi Y, Schneider M, Cellai L, Carvalho K, Sebda S, Figeac M, Eddarkaoui S, Caillierez R, Chern Y, Heneka M, Sergeant N, et al. Beneficial Effect of a Selective Adenosine A Receptor Antagonist in the APPswe/PS1dE9 Mouse Model of Alzheimer's Disease. Frontiers in Molecular Neuroscience. 11: 235. PMID 30050407 DOI: 10.3389/Fnmol.2018.00235 |
0.345 |
|
| 2018 |
Baqi Y, Pillaiyar T, Abdelrahman A, Kaufmann O, Alshaibani S, Rafehi M, Ghasimi S, Akkari R, Ritter K, Simon K, Spinrath A, Kostenis E, Zhao Q, Köse M, Namasivayam V, et al. 3-(-2-Carboxyethyl)indole-2-carboxylic Acid Derivatives: Structural Requirements and Properties of Potent Agonists of the Orphan G Protein-Coupled Receptor GPR17. Journal of Medicinal Chemistry. PMID 30048589 DOI: 10.1021/Acs.Jmedchem.7B01768 |
0.427 |
|
| 2018 |
Temido-Ferreira M, Ferreira DG, Batalha VL, Marques-Morgado I, Coelho JE, Pereira P, Gomes R, Pinto A, Carvalho S, Canas PM, Cuvelier L, Buée-Scherrer V, Faivre E, Baqi Y, Müller CE, et al. Age-related shift in LTD is dependent on neuronal adenosine A receptors interplay with mGluR5 and NMDA receptors. Molecular Psychiatry. PMID 29950682 DOI: 10.1038/S41380-018-0110-9 |
0.354 |
|
| 2017 |
Boia R, Elvas F, Madeira MH, Aires ID, Rodrigues-Neves AC, Tralhão P, Szabó EC, Baqi Y, Müller CE, Tomé ÂR, Cunha RA, Ambrósio AF, Santiago AR. Treatment with A2A receptor antagonist KW6002 and caffeine intake regulate microglia reactivity and protect retina against transient ischemic damage. Cell Death & Disease. 8: e3065. PMID 28981089 DOI: 10.1038/Cddis.2017.451 |
0.331 |
|
| 2017 |
Rafehi M, Neumann A, Baqi Y, Malik EM, Wiese M, Namasivayam V, Müller CE. Molecular recognition of agonists and antagonists by the nucleotide-activated G protein-coupled P2Y2 receptor. Journal of Medicinal Chemistry. PMID 28938069 DOI: 10.1021/Acs.Jmedchem.7B00854 |
0.401 |
|
| 2017 |
Rafehi M, Malik E, Neumann A, Abdelrahman A, Hanck T, Namasivayam V, Müller CE, Baqi Y. Development of Potent and Selective Antagonists for the UTP-Activated P2Y4 Receptor. Journal of Medicinal Chemistry. PMID 28306255 DOI: 10.1021/Acs.Jmedchem.7B00030 |
0.461 |
|
| 2017 |
Mouro FM, Batalha VL, Ferreira DG, Coelho JE, Baqi Y, Müller CE, Lopes LV, Ribeiro JA, Sebastião AM. Chronic and acute adenosine A2A receptor blockade prevents long-term episodic memory disruption caused by acute cannabinoid CB1 receptor activation. Neuropharmacology. PMID 28235548 DOI: 10.1016/J.Neuropharm.2017.02.021 |
0.377 |
|
| 2016 |
Fiene A, Baqi Y, Malik EM, Newton P, Li W, Lee SY, Hartland EL, Müller CE. Inhibitors for the bacterial ectonucleotidase Lp1NTPDase from Legionella pneumophila. Bioorganic & Medicinal Chemistry. PMID 27522579 DOI: 10.1016/J.Bmc.2016.07.027 |
0.353 |
|
| 2016 |
Batalha VL, Ferreira DG, Coelho JE, Valadas JS, Gomes R, Temido-Ferreira M, Shmidt T, Baqi Y, Buée L, Müller CE, Hamdane M, Outeiro TF, Bader M, Meijsing SH, Sadri-Vakili G, et al. The caffeine-binding adenosine A2A receptor induces age-like HPA-axis dysfunction by targeting glucocorticoid receptor function. Scientific Reports. 6: 31493. PMID 27510168 DOI: 10.1038/Srep31493 |
0.345 |
|
| 2016 |
Baqi Y. Anthraquinones as a privileged scaffold in drug discovery targeting nucleotide-binding proteins. Drug Discovery Today. PMID 27373759 DOI: 10.1016/J.Drudis.2016.06.027 |
0.37 |
|
| 2015 |
Malik EM, Baqi Y, Müller CE. Syntheses of 2-substituted 1-amino-4-bromoanthraquinones (bromaminic acid analogues) - precursors for dyes and drugs. Beilstein Journal of Organic Chemistry. 11: 2326-33. PMID 26734081 DOI: 10.3762/Bjoc.11.253 |
0.301 |
|
| 2015 |
Podurgiel SJ, Spencer T, Kovner R, Baqi Y, Müller CE, Correa M, Salamone JD. Induction of oral tremor in mice by the acetylcholinesterase inhibitor galantamine: Reversal with adenosine A2A antagonism. Pharmacology, Biochemistry, and Behavior. PMID 26459156 DOI: 10.1016/J.Pbb.2015.10.008 |
0.314 |
|
| 2015 |
Laurent C, Burnouf S, Ferry B, Batalha VL, Coelho JE, Baqi Y, Malik E, Mariciniak E, Parrot S, Van der Jeugd A, Faivre E, Flaten V, Ledent C, D'Hooge R, Sergeant N, et al. A2A adenosine receptor deletion is protective in a mouse model of Tauopathy. Molecular Psychiatry. PMID 26216297 DOI: 10.1038/Mp.2015.115 |
0.39 |
|
| 2015 |
Paoletta S, Sabbadin D, von Kügelgen I, Hinz S, Katritch V, Hoffmann K, Abdelrahman A, Straßburger J, Baqi Y, Zhao Q, Stevens RC, Moro S, Müller CE, Jacobson KA. Modeling ligand recognition at the P2Y12 receptor in light of X-ray structural information. Journal of Computer-Aided Molecular Design. PMID 26194851 DOI: 10.1007/S10822-015-9858-Z |
0.366 |
|
| 2015 |
Kaster MP, Machado NJ, Silva HB, Nunes A, Ardais AP, Santana M, Baqi Y, Müller CE, Rodrigues AL, Porciúncula LO, Chen JF, Tomé ÂR, Agostinho P, Canas PM, Cunha RA. Caffeine acts through neuronal adenosine A2A receptors to prevent mood and memory dysfunction triggered by chronic stress. Proceedings of the National Academy of Sciences of the United States of America. 112: 7833-8. PMID 26056314 DOI: 10.1073/Pnas.1423088112 |
0.344 |
|
| 2015 |
Fuzzati-Armentero MT, Cerri S, Levandis G, Ambrosi G, Montepeloso E, Antoninetti G, Blandini F, Baqi Y, Müller CE, Volpini R, Costa G, Simola N, Pinna A. Dual target strategy: combining distinct non-dopaminergic treatments reduces neuronal cell loss and synergistically modulates l-DOPA-induced rotational behavior in a rodent model of Parkinson's disease. Journal of Neurochemistry. 134: 740-7. PMID 25962878 DOI: 10.1111/Jnc.13162 |
0.385 |
|
| 2015 |
Baqi Y. Ecto-nucleotidase inhibitors: recent developments in drug discovery. Mini Reviews in Medicinal Chemistry. 15: 21-33. PMID 25694081 DOI: 10.2174/1389557515666150219115141 |
0.337 |
|
| 2015 |
Fiene A, Baqi Y, Lecka J, Sévigny J, Müller CE. Fluorescence polarization immunoassays for monitoring nucleoside triphosphate diphosphohydrolase (NTPDase) activity. The Analyst. 140: 140-8. PMID 25372046 DOI: 10.1039/C4An01694G |
0.309 |
|
| 2014 |
Laurent C, Burnouf S, Ferry B, Batalha VL, Coelho JE, Baqi Y, Malik E, Mariciniak E, Parrot S, Van der Jeugd A, Faivre E, Flaten V, Ledent C, D'Hooge R, Sergeant N, et al. A2A adenosine receptor deletion is protective in a mouse model of Tauopathy. Molecular Psychiatry. PMID 25450226 DOI: 10.1038/Mp.2014.151 |
0.341 |
|
| 2014 |
Sassi Y, Ahles A, Truong DJ, Baqi Y, Lee SY, Husse B, Hulot JS, Foinquinos A, Thum T, Müller CE, Dendorfer A, Laggerbauer B, Engelhardt S. Cardiac myocyte-secreted cAMP exerts paracrine action via adenosine receptor activation. The Journal of Clinical Investigation. 124: 5385-97. PMID 25401477 DOI: 10.1172/Jci74349 |
0.32 |
|
| 2014 |
Hoffmann K, Lutz DA, Straßburger J, Baqi Y, Müller CE, von Kügelgen I. Competitive mode and site of interaction of ticagrelor at the human platelet P2Y12 -receptor. Journal of Thrombosis and Haemostasis : Jth. 12: 1898-905. PMID 25186974 DOI: 10.1111/Jth.12719 |
0.375 |
|
| 2014 |
Horváth G, Gölöncsér F, Csölle C, Király K, Andó RD, Baranyi M, Koványi B, Máté Z, Hoffmann K, Algaier I, Baqi Y, Müller CE, Von Kügelgen I, Sperlágh B. Central P2Y12 receptor blockade alleviates inflammatory and neuropathic pain and cytokine production in rodents. Neurobiology of Disease. 70: 162-78. PMID 24971933 DOI: 10.1016/J.Nbd.2014.06.011 |
0.358 |
|
| 2014 |
Randall PA, Lee CA, Nunes EJ, Yohn SE, Nowak V, Khan B, Shah P, Pandit S, Vemuri VK, Makriyannis A, Baqi Y, Müller CE, Correa M, Salamone JD. The VMAT-2 inhibitor tetrabenazine affects effort-related decision making in a progressive ratio/chow feeding choice task: reversal with antidepressant drugs. Plos One. 9: e99320. PMID 24937131 DOI: 10.1371/Journal.Pone.0099320 |
0.344 |
|
| 2014 |
Jerónimo-Santos A, Batalha VL, Müller CE, Baqi Y, Sebastião AM, Lopes LV, Diógenes MJ. Impact of in vivo chronic blockade of adenosine A2A receptors on the BDNF-mediated facilitation of LTP. Neuropharmacology. 83: 99-106. PMID 24747180 DOI: 10.1016/J.Neuropharm.2014.04.006 |
0.355 |
|
| 2014 |
Cerri S, Levandis G, Ambrosi G, Montepeloso E, Antoninetti GF, Franco R, Lanciego JL, Baqi Y, Müller CE, Pinna A, Blandini F, Armentero MT. Neuroprotective potential of adenosine A2A and cannabinoid CB1 receptor antagonists in an animal model of Parkinson disease. Journal of Neuropathology and Experimental Neurology. 73: 414-24. PMID 24709676 DOI: 10.1097/Nen.0000000000000064 |
0.351 |
|
| 2014 |
Pinna A, Bonaventura J, Farré D, Sánchez M, Simola N, Mallol J, Lluís C, Costa G, Baqi Y, Müller CE, Cortés A, McCormick P, Canela EI, Martínez-Pinilla E, Lanciego JL, et al. L-DOPA disrupts adenosine A(2A)-cannabinoid CB(1)-dopamine D(2) receptor heteromer cross-talk in the striatum of hemiparkinsonian rats: biochemical and behavioral studies. Experimental Neurology. 253: 180-91. PMID 24412491 DOI: 10.1016/J.Expneurol.2013.12.021 |
0.401 |
|
| 2014 |
Baqi Y, Alshaibani S, Ritter K, Abdelrahman A, Spinrath A, Kostenis E, Müller CE. Improved synthesis of 4-/6-substituted 2-carboxy-1H-indole-3-propionic acid derivatives and structure-activity relationships as GPR17 agonists Medchemcomm. 5: 86-92. DOI: 10.1039/C3Md00309D |
0.385 |
|
| 2013 |
Nunes EJ, Randall PA, Hart EE, Freeland C, Yohn SE, Baqi Y, Müller CE, López-Cruz L, Correa M, Salamone JD. Effort-related motivational effects of the VMAT-2 inhibitor tetrabenazine: implications for animal models of the motivational symptoms of depression. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 19120-30. PMID 24305809 DOI: 10.1523/Jneurosci.2730-13.2013 |
0.31 |
|
| 2013 |
Silva CG, Métin C, Fazeli W, Machado NJ, Darmopil S, Launay PS, Ghestem A, Nesa MP, Bassot E, Szabó E, Baqi Y, Müller CE, Tomé AR, Ivanov A, Isbrandt D, et al. Adenosine receptor antagonists including caffeine alter fetal brain development in mice. Science Translational Medicine. 5: 197ra104. PMID 23926202 DOI: 10.1126/Scitranslmed.3006258 |
0.367 |
|
| 2013 |
Podurgiel SJ, Nunes EJ, Yohn SE, Barber J, Thompson A, Milligan M, Lee CA, López-Cruz L, Pardo M, Valverde O, Lendent C, Baqi Y, Müller CE, Correa M, Salamone JD. The vesicular monoamine transporter (VMAT-2) inhibitor tetrabenazine induces tremulous jaw movements in rodents: implications for pharmacological models of parkinsonian tremor. Neuroscience. 250: 507-19. PMID 23867769 DOI: 10.1016/J.Neuroscience.2013.07.008 |
0.388 |
|
| 2013 |
Collins-Praino LE, Paul NE, Ledgard F, Podurgiel SJ, Kovner R, Baqi Y, Müller CE, Senatus PB, Salamone JD. Deep brain stimulation of the subthalamic nucleus reverses oral tremor in pharmacological models of parkinsonism: interaction with the effects of adenosine A2A antagonism. The European Journal of Neuroscience. 38: 2183-91. PMID 23600953 DOI: 10.1111/Ejn.12212 |
0.325 |
|
| 2013 |
Pardo M, López-Cruz L, Valverde O, Ledent C, Baqi Y, Müller CE, Salamone JD, Correa M. Effect of subtype-selective adenosine receptor antagonists on basal or haloperidol-regulated striatal function: studies of exploratory locomotion and c-Fos immunoreactivity in outbred and A(2A)R KO mice. Behavioural Brain Research. 247: 217-26. PMID 23557694 DOI: 10.1016/J.Bbr.2013.03.035 |
0.443 |
|
| 2013 |
Salamone JD, Collins-Praino LE, Pardo M, Podurgiel SJ, Baqi Y, Müller CE, Schwarzschild MA, Correa M. Conditional neural knockout of the adenosine A(2A) receptor and pharmacological A(2A) antagonism reduce pilocarpine-induced tremulous jaw movements: studies with a mouse model of parkinsonian tremor. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 972-7. PMID 22947264 DOI: 10.1016/J.Euroneuro.2012.08.004 |
0.363 |
|
| 2013 |
Batalha VL, Pego JM, Fontinha BM, Costenla AR, Valadas JS, Baqi Y, Radjainia H, Müller CE, Sebastião AM, Lopes LV. Adenosine A(2A) receptor blockade reverts hippocampal stress-induced deficits and restores corticosterone circadian oscillation. Molecular Psychiatry. 18: 320-31. PMID 22371048 DOI: 10.1038/Mp.2012.8 |
0.384 |
|
| 2012 |
Randall PA, Pardo M, Nunes EJ, López Cruz L, Vemuri VK, Makriyannis A, Baqi Y, Müller CE, Correa M, Salamone JD. Dopaminergic modulation of effort-related choice behavior as assessed by a progressive ratio chow feeding choice task: pharmacological studies and the role of individual differences. Plos One. 7: e47934. PMID 23110135 DOI: 10.1371/Journal.Pone.0047934 |
0.304 |
|
| 2012 |
Müller CE, Schiedel AC, Baqi Y. Allosteric modulators of rhodopsin-like G protein-coupled receptors: opportunities in drug development. Pharmacology & Therapeutics. 135: 292-315. PMID 22728155 DOI: 10.1016/J.Pharmthera.2012.06.002 |
0.38 |
|
| 2012 |
Santerre JL, Nunes EJ, Kovner R, Leser CE, Randall PA, Collins-Praino LE, Lopez Cruz L, Correa M, Baqi Y, Müller CE, Salamone JD. The novel adenosine A(2A) antagonist prodrug MSX-4 is effective in animal models related to motivational and motor functions. Pharmacology, Biochemistry, and Behavior. 102: 477-87. PMID 22705392 DOI: 10.1016/J.Pbb.2012.06.009 |
0.419 |
|
| 2012 |
Baqi Y, Müller CE. Convergent synthesis of the potent P2Y receptor antagonist MG 50-3-1 based on a regioselective Ullmann coupling reaction. Molecules (Basel, Switzerland). 17: 2599-615. PMID 22391596 DOI: 10.3390/Molecules17032599 |
0.417 |
|
| 2012 |
Pardo M, Lopez-Cruz L, Valverde O, Ledent C, Baqi Y, Müller CE, Salamone JD, Correa M. Adenosine A2A receptor antagonism and genetic deletion attenuate the effects of dopamine D2 antagonism on effort-based decision making in mice. Neuropharmacology. 62: 2068-77. PMID 22261384 DOI: 10.1016/J.Neuropharm.2011.12.033 |
0.405 |
|
| 2012 |
Baqi Y, Müller CE. Efficient and mild deamination procedure for 1-aminoanthraquinones yielding a diverse library of novel derivatives with potential biological activity Tetrahedron Letters. 53: 6739-6742. DOI: 10.1016/J.Tetlet.2012.09.011 |
0.32 |
|
| 2011 |
Collins LE, Paul NE, Abbas SF, Leser CE, Podurgiel SJ, Galtieri DJ, Chrobak JJ, Baqi Y, Müller CE, Salamone JD. Oral tremor induced by galantamine in rats: a model of the parkinsonian side effects of cholinomimetics used to treat Alzheimer's disease. Pharmacology, Biochemistry, and Behavior. 99: 414-22. PMID 21640750 DOI: 10.1016/J.Pbb.2011.05.026 |
0.351 |
|
| 2011 |
Randall PA, Nunes EJ, Janniere SL, Stopper CM, Farrar AM, Sager TN, Baqi Y, Hockemeyer J, Müller CE, Salamone JD. Stimulant effects of adenosine antagonists on operant behavior: differential actions of selective A2A and A1 antagonists. Psychopharmacology. 216: 173-86. PMID 21347642 DOI: 10.1007/S00213-011-2198-3 |
0.382 |
|
| 2011 |
Baqi Y, Hausmann R, Rosefort C, Rettinger J, Schmalzing G, Müller CE. Discovery of potent competitive antagonists and positive modulators of the P2X2 receptor. Journal of Medicinal Chemistry. 54: 817-30. PMID 21207957 DOI: 10.1021/Jm1012193 |
0.46 |
|
| 2010 |
Baqi Y, Müller CE. Synthesis of alkyl- and aryl-amino-substituted anthraquinone derivatives by microwave-assisted copper(0)-catalyzed Ullmann coupling reactions. Nature Protocols. 5: 945-53. PMID 20431540 DOI: 10.1038/Nprot.2010.63 |
0.31 |
|
| 2010 |
Baqi Y, Lee SY, Iqbal J, Ripphausen P, Lehr A, Scheiff AB, Zimmermann H, Bajorath J, Müller CE. Development of potent and selective inhibitors of ecto-5'-nucleotidase based on an anthraquinone scaffold. Journal of Medicinal Chemistry. 53: 2076-86. PMID 20146483 DOI: 10.1021/Jm901851T |
0.387 |
|
| 2009 |
Hoffmann K, Baqi Y, Morena MS, Glänzel M, Müller CE, von Kügelgen I. Interaction of new, very potent non-nucleotide antagonists with Arg256 of the human platelet P2Y12 receptor. The Journal of Pharmacology and Experimental Therapeutics. 331: 648-55. PMID 19690189 DOI: 10.1124/Jpet.109.156687 |
0.427 |
|
| 2009 |
Baqi Y, Atzler K, Köse M, Glänzel M, Müller CE. High-affinity, non-nucleotide-derived competitive antagonists of platelet P2Y12 receptors. Journal of Medicinal Chemistry. 52: 3784-93. PMID 19463000 DOI: 10.1021/Jm9003297 |
0.448 |
|
| 2009 |
Baqi Y, Giroux S, Corey EJ. A study of the epoxidation of cycloolefins by the t-BuOH copper-permanganate system. Organic Letters. 11: 959-61. PMID 19182889 DOI: 10.1021/Ol802923N |
0.352 |
|
| 2009 |
Baqi Y, Weyler S, Iqbal J, Zimmermann H, Müller CE. Structure-activity relationships of anthraquinone derivatives derived from bromaminic acid as inhibitors of ectonucleoside triphosphate diphosphohydrolases (E-NTPDases). Purinergic Signalling. 5: 91-106. PMID 18528783 DOI: 10.1007/S11302-008-9103-5 |
0.327 |
|
| 2008 |
Weyler S, Baqi Y, Hillmann P, Kaulich M, Hunder AM, Müller IA, Müller CE. Combinatorial synthesis of anilinoanthraquinone derivatives and evaluation as non-nucleotide-derived P2Y2 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 18: 223-7. PMID 18006312 DOI: 10.1016/J.Bmcl.2007.10.082 |
0.425 |
|
| 2007 |
Baqi Y, Müller CE. Catalyst-free microwave-assisted amination of 2-chloro-5-nitrobenzoic acid. The Journal of Organic Chemistry. 72: 5908-11. PMID 17585825 DOI: 10.1021/Jo070731I |
0.306 |
|
| 2007 |
Baqi Y, Müller CE. Rapid and efficient microwave-assisted copper(0)-catalyzed ullmann coupling reaction: general access to anilinoanthraquinone derivatives. Organic Letters. 9: 1271-4. PMID 17348665 DOI: 10.1021/Ol070102V |
0.301 |
|
| 2006 |
Müller CE, Iqbal J, Baqi Y, Zimmermann H, Röllich A, Stephan H. Polyoxometalates--a new class of potent ecto-nucleoside triphosphate diphosphohydrolase (NTPDase) inhibitors. Bioorganic & Medicinal Chemistry Letters. 16: 5943-7. PMID 16997558 DOI: 10.1016/J.Bmcl.2006.09.003 |
0.304 |
|
| Show low-probability matches. |